Determinants of poor hypertension management in patients with ischaemic heart disease

Blood Pressure

Volumn 14, Issue 5, 2005, Pages 284-292

  Jankowski, Piotr ^a   Kawecka Jaszcz, Kalina ^a,b   Bilo, Grzegorz ^a   Pajak, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE   (Poland)

Author keywords

Blood pressure; Hypertension; Ischaemic heart disease; Quality of medical care; Risk factor

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART INFARCTION; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL RECORD; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SECONDARY PREVENTION; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; UNSTABLE ANGINA PECTORIS;

AGED; ANTIHYPERTENSIVE AGENTS; DISEASE MANAGEMENT; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; INTERVIEWS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 28244472276     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050500239962     Document Type: Article

References (31)

1. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
2. Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults. The Cardiovascular Health Study. Arch Intern Med. 2002;162:2325-2332.
3. Maziak W, Keil U, Doring A, Hense HW. Determinants of poor hypertension management in community. J Hum Hypertens. 2003;17:215-217.
4. Rywik SL, Davis CE, Pajak A, Broda G, Folsom AR, Kawalec E, et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: Prevalence, awareness, treatment, and control of hypertension in the Pol-Monica Project and the U.S. Atherosclerosis Risk in Communities Study. Ann Epidemiol. 1998;8:3-13.
5. Benitez M, Codina N, Dalfo A, Vila MA, Escriba JM, Senar E, et al. Control of blood pressure in a population of patients with hypertension and in a subgroup with hypertension and diabetes: Relationship with characteristics of the health care center and the community. Aten Primaria. 2001;28:373-80.
6. Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Goke B, et al. High prevalence and poor control of hypertension in primary care: Cross-sectional study. J Hypertens. 2004;22:479-486.
7. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809-814.
8. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051-1058.
9. Llyod-Jones DM, Evans JC, Larson MG, Levy D. Treatment and control of hypertension in the community: A prospective analysis. Hypertension. 2002;40:640-646.
10. Boersma E, Keil U, De Bacquer D, De Backer G, Pyorala K, Poldermans D, et al. EUROASPIRE I and II Study Groups. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens. 2003;21:1831-1840.
11. Flanagan DE, Cox P, Paine D, Davies J, Armitage M. Secondary prevention of coronary heart disease in primary care: A healthy heart initiative. QJM. 1999;92:245-250.
12. Pearson TA, Peters TD, Feury D. Comprehensive risk reduction in coronary patients: Attainment of goals of the AHA Guidelines in U.S. patients. Circulation. 1997;96(8S): 733-I.
13. Lawlor DA, Whincup P, Emberson JR, Rees K, Walker M, Ebrahim S. The challenge of secondary prevention for coronary heart disease in older patients: Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Fam Pract. 2004;21:582-586.
14. Tonstad SD, Furu K, Rosvold EO, Skurtveit S. Determinants of control of high blood pressure. The Oslo Health Study. 2000-2001. Blood Press. 2004;13:343-349.
15. Amar J, Chamontin B, Ferrieres J, Danchin N, Grenier O, Cantet C. Hypertension control at hospital discharge after acute coronary event: Influence on cardiovascular prognosis - the PREVENIR study. Heart. 2002;88:587-591.
16. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet. 2001;358:1682-1686.
17. Kawecka-Jaszcz K, Jankowski P, Pajak A. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Intern J Cardiol. 2003;91:15-23.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL. Jr. The Seventh Report of the Joint National Committee on Prevention., Detection., Evaluation., and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
19. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
20. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461-1464.
21. Asmar R, Benetos A, London G, Hugue C, Weiss Y, Topouchian J, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press. 1995;4:48-54.
22. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434-1503.
23. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1428.
24. Kawecka-Jaszcz K, Januszewicz W, Rywik S, Sznajderman M. Nadciśnienie tetnicze pierwotne. Kardiol Pol. 1997;XLVI(Suppl I):86-97.
25. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens. 2003;21:1199-1205.
26. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1725-1727.
27. de Macendo CR, Noblat AC, Noblat L, de Macedo JM, Lopes AA. Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients. Arq Bras Cardiol. 2001;77:328-331.
28. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
29. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
30. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians. Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281-2286.
31. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.